No authorised photograph is on file for this profile. The initials shown are a typographic placeholder, not a likeness.
Managing Partner at Meridian Sur Ventures
Confirmed against at least one cited public source.
Adriana Solano Reyes is a venture capital profiled in the Global Leadership and Investors directory, listed as Managing Partner at Meridian Sur Ventures and based in Mexico City, Mexico. The profile records 3 publicly reported investments, 2 cited sources and 0 official links. All figures shown are limited to those disclosed publicly; none are estimated.
Overview
The profile format is designed to hold a neutral, factual account of a subject's professional background: the roles they have held, the organisations they are publicly associated with, and the investment activity that has been reported by identifiable sources. Promotional language, unsourced claims and speculation about private matters are outside the editorial standard.
Attributes
Attributes recorded for this profile. Fields with no public source are marked rather than estimated.
Transactions
Transactions identified in public sources. Amounts appear only where publicly disclosed.
| Company | Sector | Country | Year | Stage | Disclosed amount | Status |
|---|---|---|---|---|---|---|
| Sample Logistics PlatformLead investor | Mexico (MX)Mexico | 2023 | Series A | Not disclosed | VerifiedView source | |
| Sample Developer Tooling CompanyParticipant | Mexico (MX)Mexico | 2022 | Seed | $4M | VerifiedView source | |
| Sample Fintech Infrastructure CompanyParticipant | Colombia (CO)Colombia | 2021 | Pre-Seed | Not disclosed | Verified |
Amounts appear only where a figure was publicly disclosed and recorded against a source. Where no amount is shown, none was disclosed — figures are never estimated or inferred from round size.
Affiliations
Organisations this profile is publicly associated with, and the board seats recorded for it.
Non-executive director
Andes Digital Group · since 2022
VerifiedTimeline
Summarised public mentions. Full third-party article text is never reproduced — each entry links to the original publisher.
Global Leadership and Investors Editorial Desk
Why transaction disclosure across Mexico, Colombia and Brazil differs from North American practice, and what that means for the completeness of a regional profile.
Source: Global Leadership and Investors Editorial Desk
Global Leadership and Investors Editorial Desk
Capability and valuation claims in AI are frequently reported without attribution. An outline of the stricter standard the directory applies to profiles in this sector.
Source: Global Leadership and Investors Editorial Desk
Documents
Official and publicly available material. Copyrighted documents are linked at the publisher, never mirrored here.
No official biographies, filings, reports or press material have been linked to this profile yet.
Evidence
Every source consulted for this profile, with the date it was last accessed.
Meridian Sur Ventures (sample organisation) · Demo Placeholder · Accessed 1 July 2026
Global Leadership and Investors Editorial Desk · Demo Placeholder · Published 14 September 2022 · Accessed 1 July 2026
Believe something on this page is inaccurate or out of date? Corrections are welcomed from the subject of a profile, from any organisation named on it, and from readers who can point to a source. See theeditorial policy for how corrections are handled.
Related
Profiles sharing an organisation, sector, country or investor type with this one.
Venture Capital
Founding Partner · Thames Foundry
United Kingdom (GB)London, United Kingdom
A founding partner at a London applied-AI venture firm, covered in the directory as an artificial intelligence investor.
View profile
Venture Capital
Partner · Wisła Growth
Poland (PL)Warsaw, Poland
A partner at a Warsaw growth-stage venture firm, covered in the directory as a Central European investor.
View profile
Venture Capital
General Partner · Rive Gauche Capital
France (FR)Paris, France
A general partner at a Paris life sciences venture firm, covered in the directory as a healthcare and biotechnology investor.
View profile
